{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T08:49:52Z","timestamp":1747817392398,"version":"3.37.3"},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T00:00:00Z","timestamp":1722988800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,3]]},"abstract":"<jats:p>This scientific commentary refers to \u2018Leriglitazone halts disease progression in adult patients with early cerebral adrenoleukodystrophy\u2019 by Golse et al. (https:\/\/doi.org\/10.1093\/brain\/awae169).<\/jats:p>","DOI":"10.1093\/brain\/awae261","type":"journal-article","created":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T00:01:11Z","timestamp":1723075271000},"page":"3271-3273","source":"Crossref","is-referenced-by-count":1,"title":["An alternative therapeutic approach to haematopoetic stem cell transplantation in early cerebral adrenoleukodystrophy"],"prefix":"10.1093","volume":"147","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7286-6901","authenticated-orcid":false,"given":"Jeremy","family":"Chataway","sequence":"first","affiliation":[{"name":"Queen Square Multiple Sclerosis Centre, Department of Neuroinflammation, UCL Queen Square Institute of Neurology, Faculty of Brain Sciences, University College London , London, WC1N 5EH ,","place":["UK"]},{"name":"Inherited White Matters Disorders Highly Specialised Service, National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust , London, WC1N 3BG ,","place":["UK"]},{"name":"National Institute for Health Research, University College London Hospitals, Biomedical Research Centre , London, W1T 7DN ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Wade","sequence":"additional","affiliation":[{"name":"Queen Square Multiple Sclerosis Centre, Department of Neuroinflammation, UCL Queen Square Institute of Neurology, Faculty of Brain Sciences, University College London , London, WC1N 5EH ,","place":["UK"]},{"name":"Inherited White Matters Disorders Highly Specialised Service, National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust , London, WC1N 3BG ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elaine","family":"Murphy","sequence":"additional","affiliation":[{"name":"Inherited White Matters Disorders Highly Specialised Service, National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust , London, WC1N 3BG ,","place":["UK"]},{"name":"Charles Dent Metabolic Unit, University College London Hospitals NHS Foundation Trust National Hospital for Neurology and Neurosurgery , London, WC1N 3AX ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0615-7159","authenticated-orcid":false,"given":"David S","family":"Lynch","sequence":"additional","affiliation":[{"name":"Inherited White Matters Disorders Highly Specialised Service, National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust , London, WC1N 3BG ,","place":["UK"]},{"name":"Department of Neuromuscular Disease, UCL Queen Square Institute of Neurology , London, WC1N 3BG ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,8,7]]},"reference":[{"key":"2024100318020401900_awae261-B1","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1212\/WNL.0000000000001074","article-title":"Frequent occurrence of cerebral demyelination in adrenomyeloneuropathy","volume":"83","author":"de Beer","year":"2014","journal-title":"Neurology"},{"key":"2024100318020401900_awae261-B2","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1210\/jc.2018-01307","article-title":"The natural history of adrenal insufficiency in X-linked adrenoleukodystrophy: An international collaboration","volume":"104","author":"Huffnagel","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"2024100318020401900_awae261-B3","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/brain\/awy299","article-title":"Progression of myelopathy in males with adrenoleukodystrophy: Towards clinical trial readiness","volume":"142","author":"Huffnagel","year":"2019","journal-title":"Brain"},{"key":"2024100318020401900_awae261-B4","first-page":"92","article-title":"MRI brain lesions in asymptomatic boys with X-linked adrenoleukodystrophy","volume":"19","author":"Liberato","year":"2019","journal-title":"BMC Neurol."},{"key":"2024100318020401900_awae261-B5","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1093\/brain\/awx016","article-title":"Long-term outcomes of allogeneic haematopoietic stem cell transplantation for adult cerebral X-linked adrenoleukodystrophy","volume":"140","author":"K\u00fchl","year":"2017","journal-title":"Brain"},{"key":"2024100318020401900_awae261-B6","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.3390\/ijms24043201","article-title":"Development of PPAR\u03b3 agonists for the treatment of neuroinflammatory and neurodegenerative diseases: Leriglitazone as a promising candidate","volume":"24","author":"Pizcueta","year":"2023","journal-title":"Int J Mol Sci"},{"key":"2024100318020401900_awae261-B7","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S1474-4422(22)00495-1","article-title":"Safety and efficacy of leriglitazone for preventing disease progression in men with adrenomyeloneuropathy (ADVANCE): A randomised, double-blind, multi-centre, placebo-controlled phase 2\u20133 trial","volume":"22","author":"K\u00f6hler","year":"2023","journal-title":"Lancet Neurol"},{"author":"Mallack","key":"2024100318020401900_awae261-B8"},{"key":"2024100318020401900_awae261-B9","doi-asserted-by":"crossref","first-page":"3344","DOI":"10.1093\/brain\/awae169","article-title":"Leriglitazone halts disease progression in adult patients with early cerebral adrenoleukodystrophy","volume":"147","author":"Golse","year":"2024","journal-title":"Brain"},{"key":"2024100318020401900_awae261-B10","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S1474-4422(22)00518-X","article-title":"Leriglitazone: Frustration and hope in adrenoleukodystrophy","volume":"22","author":"Sch\u00f6ls","year":"2023","journal-title":"Lancet Neurol"}],"container-title":["Brain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/brain\/advance-article-pdf\/doi\/10.1093\/brain\/awae261\/58992214\/awae261.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/brain\/article-pdf\/147\/10\/3271\/59560942\/awae261.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/brain\/article-pdf\/147\/10\/3271\/59560942\/awae261.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T01:01:28Z","timestamp":1732582888000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/brain\/article\/147\/10\/3271\/7729175"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,7]]},"references-count":10,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2024,8,7]]},"published-print":{"date-parts":[[2024,10,3]]}},"URL":"https:\/\/doi.org\/10.1093\/brain\/awae261","relation":{},"ISSN":["0006-8950","1460-2156"],"issn-type":[{"type":"print","value":"0006-8950"},{"type":"electronic","value":"1460-2156"}],"subject":[],"published-other":{"date-parts":[[2024,10]]},"published":{"date-parts":[[2024,8,7]]}}}